Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 8/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9398033 | 1.00 | L3MBTL1 (0.49) | L3MBTL1TDP1SIGMAR1CES1MAOA | |
| SCHEMBL9398140 | 1.00 | L3MBTL1 (0.49) | L3MBTL1TDP1SIGMAR1CES1MAOA | |
| SCHEMBL16293300 | 1.00 | L3MBTL1 (0.49) | L3MBTL1TDP1SIGMAR1CES1MAOA | |
| SCHEMBL18979316 | 1.00 | L3MBTL1 (0.49) | L3MBTL1TDP1SIGMAR1CES1MAOA | |
| SCHEMBL9395958 | 1.00 | L3MBTL1 (0.49) | L3MBTL1TDP1SIGMAR1CES1MAOA | |
| SCHEMBL18979278 | 1.00 | L3MBTL1 (0.49) | L3MBTL1TDP1SIGMAR1CES1MAOA | |
| SCHEMBL2748794 | 0.98 | L3MBTL1 (0.47) | L3MBTL1TDP1SIGMAR1MAOA | |
| SCHEMBL2822247 | 0.92 | IDO1 (0.45) | L3MBTL1TDP1SIGMAR1MAOA | |
| SCHEMBL25242964 | 0.88 | CALM1 (0.44) | L3MBTL1TDP1 | |
| SCHEMBL9863890 | 0.84 | KCNH2 (0.51) | L3MBTL1TDP1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12319815-B2 | Resin composition, method for producing same, and multi-liquid curable resin composition | KANEKA CORPORATION (JP) | 2025-06-03 | — | — | US | disclosed |
| US-12312494-B2 | Resin composition, method for producing same, and multi-liquid curable resin composition | KANEKA CORPORATION (JP) | 2025-05-27 | — | — | US | disclosed |
| CN-115003759-B | Resin composition, method for producing same, and multicomponent curable resin composition | 株式会社钟化 | 2023-12-01 | — | — | CN | disclosed |
| CN-116917368-A | Curable resin composition and use thereof | 株式会社钟化 | 2023-10-20 | — | — | CN | disclosed |
| CN-114008113-B | Resin composition, method for producing same, and multicomponent curable resin composition | 株式会社钟化 | 2023-05-02 | — | — | CN | disclosed |
| US-20220340777-A1 | RESIN COMPOSITION, METHOD FOR PRODUCING SAME, AND MULTI-LIQUID CURABLE RESIN COMPOSITION | KANEKA CORPORATION (JP) | 2022-10-27 | — | — | US | disclosed |
| WO-2022202173-A1 | CURABLE RESIN COMPOSITION AND USE THEREOF | 株式会社カネカ | 2022-09-29 | — | — | WO | disclosed |
| CN-115003759-A | Resin composition, method for producing same, and multi-component curable resin composition | 株式会社钟化 | 2022-09-02 | — | — | CN | disclosed |
| CN-110651336-B | Conductive paste composition, electrode device comprising same, and method for producing conductive paste composition | 株式会社钟化 | 2022-05-17 | — | — | CN | disclosed |
| US-20220073747-A1 | RESIN COMPOSITION, METHOD FOR PRODUCING SAME, AND MULTI-LIQUID CURABLE RESIN COMPOSITION | KANEKA CORPORATION (JP) | 2022-03-10 | — | — | US | disclosed |
| CN-107001583-B | Photocurable and thermosetting resin composition, cured product, and laminate | 株式会社钟化 | 2019-06-18 | — | — | CN | disclosed |
| US-10227505-B2 | Active energy ray-curable composition | KANEKA CORPORATION (JP) | 2019-03-12 | — | — | US | disclosed |
| US-20180219160-A1 | BENZOBIS(THIADIAZOLE) DERIVATIVE, INK COMPRISING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2018-08-02 | — | — | US | disclosed |
| EP-3235845-A1 | PHOTOCURABLE AND THERMOSETTING RESIN COMPOSITION, CURED PRODUCT AND LAMINATE | Kaneka Corporation (JP) | 2017-10-25 | — | — | EP | disclosed |
| US-20170283649-A1 | PHOTOCURABLE AND THERMOSETTING RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | KANEKA CORPORATION (JP) | 2017-10-05 | — | — | US | disclosed |
| CN-107001583-A | Photocurable and thermosetting resin composition, cured product, and laminate | 株式会社钟化 | 2017-08-01 | — | — | CN | disclosed |
| EP-3181569-A1 | BENZOBIS(THIADIAZOLE) DERIVATIVE, INK CONTAINING SAME, AND ORGANIC ELECTRONIC DEVICE USING SAME | UBE Industries, Ltd. (JP) | 2017-06-21 | — | — | EP | disclosed |
| US-20160145467-A1 | ACTIVE ENERGY RAY-CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2016-05-26 | — | — | US | disclosed |
| CN-105324407-A | Active energy ray-curable composition | KANEKA CORP | 2016-02-10 | — | — | CN | disclosed |
| US-5356471-A | Pigments of dark surface color | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1994-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180219160-A1 | BENZOBIS(THIADIAZOLE) DERIVATIVE, INK COMPRISING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | IKZF3, HELZ, TEC | L3MBTL1 998/4885TDP1 791/4885SIGMAR1 3454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.